Suchergebnisse

SummaryThe demand for postpartum sterilisation (performed within 42 days after delivery), is increasing both in developed and developing countries. The incidence of regret after postpartum sterilisation is important, but it could be minimised by carefully screening risk factors. Using trained paramedical personnel to perform postpartum sterilisation via minilaparotomy where physicians are in short supply appears to be safe and acceptable, under close medical supervision. Including postpartum sterilisation information in the antenatal counselling services effectively strengthens postpartum services and simultaneously helps to minimise subsequent regret.

SummaryThis paper reviews the historical development of the IUD, describing the challenges and successes, and attempts to offer a balanced perspective for family planning service workers today. Modern IUDs are an important component of family planning services and an excellent contraceptive choice for properly screened women, providing contraception that is safe, effective, long lasting and cost effective. Potential research strategies for the future are also discussed.

SummaryDepot medroxyprogesterone acetate (DMPA) was approved as an investigational new drug for contraceptive use in the United States between 1967 and 1978. Patterns of contraceptive choice and changing methods were determined among 36,298 women attending a family planning clinic between 1967 and 1976. This population was the largest concentration of US women who had DMPA available as a contraceptive option. By 1974, women in the age group 35–49 were as likely to choose DMPA as either oral contraception or an intrauterine device. Coincidentally, use of the most popular choice, oral contraception, declined in older women and IUD use dropped sharply in all age groups. On average, users of DMPA were more likely to continue their method than were users of IUDs or barrier methods. Among women in the 35–49 age group, DMPA users were the group least likely to change methods.